Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development

Journal of Pharmaceutical Sciences

Volumn 99, Issue 7, 2010, Pages 2941-2947

  Qian, Feng ^a   Huang, Jun ^a   Hussain, Munir A ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Amorphous solid dispersion; Drug loading; Glass transition temperature; Miscibility; Physical stability; Solubility

Indexed keywords

DRUG CARRIER; POLYMER;

CRYSTALLIZATION; DISPERSION; DRUG FORMULATION; DRUG STORAGE; MISCIBILITY; NOTE; SOLUBILITY; THERMODYNAMICS; WETTABILITY;

EID: 77953296607     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22074     Document Type: Note

References (44)

1. Hancock BC, Zografi G. 1997. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86:1-12. (Pubitemid 127489650)
2. Yu L. 2001. Amorphous pharmaceutical solids: Preparation, characterization and stabilization. Adv Drug Deliv Rev 48:27-42. (Pubitemid 32454482)
3. Hancock BC, Shamblin SL, Zografi G. 1995. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res 12:799-806.
4. Hancock BC. 2002. Disordered drug delivery: Destiny, dynamics and the Deborah number. J Pharm Pharmacol 54: 737-746.
5. Sekiguchi K, Obi N, Ueda Y. 1964. Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull (Tokyo) 9:866-872.
6. Sekiguchi K, Obi N, Ueda Y. 1964. Studies on absorption of eutectic mixture. II. Absorption of fused conglomerates of chloramphenicol and urea in rabbits. Chem Pharm Bull (Tokyo) 12:134-144.
7. Repka MA, Majumdar S, Kumar BS, Srirangam R, Upadhye SB. 2008. Applications of hot-melt extrusion for drug delivery. Expert Opin Drug Deliv 5:1357-1376.
8. Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50:47-60. (Pubitemid 30326688)
9. Fatouros DG, Karpf DM, Nielsen FS, Mullertz A. 2007. Clinical studies with oral lipid based formulations of poorly soluble compounds. Ther Clin Risk Manag 3:591-604. (Pubitemid 47496964)
10. Gao P, Morozowich W. 2006. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv 3:97-110. (Pubitemid 43056394)
11. Chen Y, Zhang GG, Neilly J, Marsh K, Mawhinney D, Sanzgiri YD. 2004. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. Int J Pharm 286:69-80. (Pubitemid 39410474)
12. Law D, Krill SL, Schmitt EA, Fort JJ, Qiu Y, Wang W, Porter WR. 2001. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions. J Pharm Sci 90:1015-1025.
13. Zerrouk N, Chemtob C, Arnaud P, Toscani S, Dugue J. 2001. In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int J Pharm 225:49-62.
14. Qian F, Tao J, Desikan S, Hussain M, Smith RL. 2007. Mechanistic investigation of Pluronic based nano-crystalline drug-polymer solid dispersions. Pharm Res 24:1551-1560. (Pubitemid 46988222)
15. Angell CA. 1995. Formation of glasses from liquids and biopolymers. Science 267:1924-1935.
16. Rumondor AC, Stanford LA, Taylor LS. 2009. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions. Pharm Res 26:2599-2606.
17. Rumondor AC, Ivanisevic I, Bates S, Alonzo DE, Taylor LS. 2009. Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. Pharm Res 26:2523-2534.
18. Taylor LS, Zografi G. 1997. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 14:1691-1698. (Pubitemid 28062912)
19. Campbell AN, Campbell AJR. 1937. Concentrations, total and partial vapor pressures, surface tensions and viscosities, in the systems phenol-water and phenol-water-4% succinic acid. J Am Chem Soc 59:2481-2488.
20. Rubinstein M, Colby RH. 2003. Thermodynamics of blends and solutions. In: Polymer physics. New York: Oxford University Press Inc,. pp 137-170.
21. Bernstein J, Davey RJ, Henck JO. 1999. Concomitant polymorphs. Angew Chem Int Ed Engl 38:3440-3461.
22. Flory PJ. 1941. Thermodynamics of high polymer solutions. J Chem Phys 9:660-661.
23. Huggins ML. 1942. Thermodynamic properties of solutions of long-chain compounds. Ann N Y Acad Sci 43:1-32.
24. Crowley KJ, Zografi G. 2002. Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions. J Pharm Sci 91:2150-2165.
25. Marsac PJ, Shamblin SL, Taylor LS. 2006. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm Res 23:2417-2426.
26. Marsac PJ, Li T, Taylor LS. 2009. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm Res 26:139-151.
27. Gordon M, Taylor J. 1952. Ideal copolymers and the secondorder transitions of synthetic rubbers. I. Noncrystalline copolymers. J Appl Chem 2:493-500.
28. Marsac PJ, Konno H, Rumondor AC, Taylor LS. 2008. Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water. Pharm Res 25:647-656. (Pubitemid 351357733)
29. Tao J, Sun Y, Zhang GG, Yu L. 2009. Solubility of small-molecule crystals in polymers: D-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA. Pharm Res 26:855-864.
30. Vasanthavada M, Tong WQ, Joshi Y, Kislalioglu MS. 2004. Phase behavior of amorphous molecular dispersions. I: Determination of the degree and mechanism of solid solubility. Pharm Res 21:1598-1606.
31. Vasanthavada M, Tong WQ, Joshi Y, Kislalioglu MS. 2005. Phase behavior of amorphous molecular dispersions. II: Role of hydrogen bonding in solid solubility and phase separation kinetics. Pharm Res 22:440-448.
32. Krause S, Iskander M. 1977. Phase separation in styrene-a-methyl styrene block copolymers. In: Klempner D, Frisch K, editors. Polymer science and technology. New York: Plenum Pub Corp 10th edition. pp 231-243.
33. Aso Y, Yoshioka S, Miyazaki T, Kawanishi T, Tanaka K, Kitamura S, Takakura A, Hayashi T, Muranushi N. 2007. Miscibility of nifedipine and hydrophilic polymers as measured by (1)H-NMR spin-lattice relaxation. Chem Pharm Bull (Tokyo) 55:1227-1231.
34. Berendt RT, Sperger DM, Munson EJ, Isbester PK. 2006. Solid-state NMR spectroscopy in pharmaceutical research and analysis. TrAC Trends Anal Chem 25:977-984. (Pubitemid 44666187)
35. Nelson BN, Schieber LJ, Barich DH, Lubach JW, Offerdahl TJ, Lewis DH, Heinrich JP, Munson EJ. 2006. Multiple-sample probe for solid-state NMR studies of pharmaceuticals. Solid State Nucl Magn Reson 29:204-213. (Pubitemid 41808386)
36. Lubach JW, Padden BE, Winslow SL, Salsbury JS, Masters DB, Topp EM, Munson EJ. 2004. Solid-state NMR studies of pharmaceutical solids in polymer matrices. Anal Bioanal Chem 378:1504-1510. (Pubitemid 40877680)
37. Geppi M, Guccione S, Mollica G, Pignatello R, Veracini CA. 2005. Molecular properties of ibuprofen and its solid dispersions with Eudragit RL100 studied by solid-state nuclear magnetic resonance. Pharm Res 22:1544-1555. (Pubitemid 41215896)
38. Newman A, Engers D, Bates S, Ivanisevic I, Kelly RC, Zografi G. 2008. Characterization of amorphous API:polymer mixtures using X-ray powder diffraction. J Pharm Sci 97:4840-4856.
39. Ivanisevic I, Bates S, Chen P. 2009. Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions. J Pharm Sci 98:3373-3386.
40. Shmeis RA, Wang Z, Krill SL. 2004. A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions. Part I: A comparative analysis by thermally stimulated depolarization current and differential scanning calorimetry. Pharm Res 21:2025-2030.
41. Shmeis RA, Wang Z, Krill SL. 2004. A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions. Part II: Molecular mobility and activation thermodynamic parameters. Pharm Res 21:2031-2039.
42. Koningsveld R. 1970. Liquid-liquid equilibria in multi-component polymer systems. Discuss Faraday Soc 49:144-161.
43. Koningsveld R, Kleintjens LA, Shultz AR. 1970. Liquid-liquid phase separation in multicomponent polymer solutions - 9. J Polym Sci Part A 2 Polym Phys 8:1261-1278.
44. Velikov V, Borick S, Angell C. 2001. The glass transition of water, based on hyperquenching. Science 294:2335-2338. (Pubitemid 33140553)